Business Context and Reporting Period
Company: Silver Spike Investment Corp. (SSIC) (Note: The filing indicates a pending name change to Chicago Atlantic BDC, Inc. upon closing of a proposed acquisition).
Reporting Period: Quarterly period ended June 30, 2024 (Form 10-Q).
Business Overview: SSIC is an externally managed, closed-end, non-diversified management investment company organized as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company primarily invests in secured debt, unsecured debt, equity warrants, and direct equity investments in private leveraged middle-market cannabis companies and health and wellness sectors. On February 20, 2024, the Board approved an expansion of its investment strategy to include companies outside the cannabis and health and wellness sectors.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2024 | Six Months Ended June 30, 2023 |
|---|---|---|
| Total Investment Income | $5,841,580 | $5,351,538 |
| Net Investment Income | $1,445,824 | $3,270,135 |
| Net Increase in Net Assets from Operations | $1,812,672 | $3,568,484 |
| Net Asset Value (NAV) per Share | $13.56 | $14.49 |
| Cash and Cash Equivalents | $34,003,851 | $32,895,660 |
| Total Assets | $90,076,727 | $88,576,271 |
| Total Liabilities | $5,818,654 | $3,023,653 |
| Portfolio Fair Value | $53,398,164 | $57,669,044 |
Liquidity: The company held approximately $34.0 million in cash and cash equivalents as of June 30, 2024, with no indebtedness. It maintains adequate liquidity to fund unfunded commitments of $1.75 million.
Material Changes vs. Prior Period
- Expense Surge: Total expenses increased by 111% to $4.4 million for the six months ended June 30, 2024, compared to $2.1 million in the prior year period. This was primarily driven by $2.6 million in transaction expenses related to the proposed Loan Portfolio Acquisition.
- Net Investment Income Decline: Net investment income decreased by approximately 56% year-over-year, largely due to the aforementioned transaction expenses, despite a 9% increase in total investment income.
- Portfolio Composition: The portfolio now includes equity securities (approx. 1.5% of fair value), a new asset class for the company as of the three months ended June 30, 2024. The portfolio remains heavily concentrated in Wholesale Trade (96.7%) and Real Estate Services (3.3%).
- Unrealized Gains: The company recorded a net change in unrealized appreciation of $366,848 for the six months ended June 30, 2024, compared to $509,116 in the prior year period.
Guidance, Outlook, and Material Events
- Proposed Loan Portfolio Acquisition: On February 18, 2024, SSIC entered into a definitive agreement to acquire a loan portfolio from Chicago Atlantic Loan Portfolio, LLC (CALP) valued at approximately $130 million (as of Jan 1, 2024) in exchange for newly issued common stock. The transaction is expected to close in mid-2024, subject to stockholder approval and other conditions.
- Corporate Restructuring: Upon closing the acquisition and a related joint venture with Chicago Atlantic, the company will be renamed Chicago Atlantic BDC, Inc. and the investment adviser will be renamed Chicago Atlantic BDC Advisers, LLC.
- Strategy Expansion: Effective April 22, 2024, the company expanded its investment strategy to permit investments outside the cannabis and health and wellness sectors.
- Distributions: The company declared quarterly dividends of $0.25 per share in March and May 2024. A subsequent dividend of $0.25 per share was approved on August 7, 2024, payable in September 2024.
- Risks: Key risks include the uncertainty of the Loan Portfolio Acquisition closing, concentration risk in the cannabis sector, and the potential for investments to trade at a discount to NAV (shares traded at an 11.7% discount to NAV as of August 6, 2024).
Investor Verification Checklist
- Acquisition Status: Verify the progress and expected closing date of the Loan Portfolio Acquisition with Chicago Atlantic Loan Portfolio, LLC, including stockholder approval status.
- Expense Run Rate: Assess whether the $2.6 million in transaction expenses are one-time costs or indicative of future operating expense levels post-acquisition.
- Portfolio Concentration: Review the concentration risk, noting that two portfolio companies represented 73.1% of the portfolio's fair value as of June 30, 2024.
- NAV Discount: Monitor the trading price of the stock relative to NAV, as the shares have historically traded at a significant discount.
- Regulatory Compliance: Confirm the company's continued qualification as a Regulated Investment Company (RIC) to avoid corporate-level taxation.